Literature DB >> 8731171

Formalin induces biphasic activity in C-fibers in the rat.

W D McCall1, K D Tanner, J D Levine.   

Abstract

While the formalin test is a widely used behavioral model of tonic chemogenic pain, little is known about the responses of primary afferent nociceptors to formalin. Formalin (2.5%, 50 microliters) was injected either directly in or adjacent to the mechanical receptive fields of single C-fibers isolated from the saphenous nerve of pentobarbital-anesthetized rats. The average formalin-evoked response in C-fibers (n = 29) over time was biphasic. This biphasic time course of the C-fiber response to formalin is similar to that of the behavioral response in the awake animal and is compatible with the hypothesis that increased C-fiber activity contributes to the behavioral response in phase 2, as well as in phase 1 of the formalin test.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8731171     DOI: 10.1016/0304-3940(96)12552-0

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  31 in total

1.  Sex differences in the potency of kappa opioids and mixed-action opioids administered systemically and at the site of inflammation against capsaicin-induced hyperalgesia in rats.

Authors:  Lisa M Lomas; Andrew C Barrett; Jolan M Terner; Donald T Lysle; Mitchell J Picker
Journal:  Psychopharmacology (Berl)       Date:  2007-01-16       Impact factor: 4.530

2.  The antinociceptive effects of intraplantar injections of 2-arachidonoyl glycerol are mediated by cannabinoid CB2 receptors.

Authors:  J Guindon; J Desroches; P Beaulieu
Journal:  Br J Pharmacol       Date:  2006-12-18       Impact factor: 8.739

3.  Light-Emitting Diode Phototherapy Reduces Nocifensive Behavior Induced by Thermal and Chemical Noxious Stimuli in Mice: Evidence for the Involvement of Capsaicin-Sensitive Central Afferent Fibers.

Authors:  Glauce Regina Pigatto; Igor Santos Coelho; Rosane Schenkel Aquino; Liliane Freitas Bauermann; Adair Roberto Soares Santos
Journal:  Mol Neurobiol       Date:  2016-04-07       Impact factor: 5.590

4.  Signal changes in the spinal cord of the rat after injection of formalin into the hindpaw: characterization using functional magnetic resonance imaging.

Authors:  R Pórszász; N Beckmann; K Bruttel; L Urban; M Rudin
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-13       Impact factor: 11.205

5.  Endogenous transient receptor potential ankyrin 1 and vanilloid 1 activity potentiates glutamatergic input to spinal lamina I neurons in inflammatory pain.

Authors:  Yuying Huang; Shao-Rui Chen; Hong Chen; Hui-Lin Pan
Journal:  J Neurochem       Date:  2019-03-26       Impact factor: 5.372

Review 6.  Predictive validity of behavioural animal models for chronic pain.

Authors:  Odd-Geir Berge
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

Review 7.  Cellular, molecular, and epigenetic mechanisms in non-associative conditioning: implications for pain and memory.

Authors:  Elizabeth J Rahn; Mikael C Guzman-Karlsson; J David Sweatt
Journal:  Neurobiol Learn Mem       Date:  2013-06-22       Impact factor: 2.877

8.  Activation of peripheral and spinal histamine H3 receptors inhibits formalin-induced inflammation and nociception, respectively.

Authors:  Keri E Cannon; Rob Leurs; Lindsay B Hough
Journal:  Pharmacol Biochem Behav       Date:  2007-07-25       Impact factor: 3.533

9.  siRNA-mediated knockdown of the NR1 subunit gene of the NMDA receptor attenuates formalin-induced pain behaviors in adult rats.

Authors:  Sandra M Garraway; Qinghao Xu; Charles E Inturrisi
Journal:  J Pain       Date:  2009-01-29       Impact factor: 5.820

10.  Dysregulation of voltage-gated sodium channels by ubiquitin ligase NEDD4-2 in neuropathic pain.

Authors:  Cédric J Laedermann; Matthieu Cachemaille; Guylène Kirschmann; Marie Pertin; Romain-Daniel Gosselin; Isabelle Chang; Maxime Albesa; Chris Towne; Bernard L Schneider; Stephan Kellenberger; Hugues Abriel; Isabelle Decosterd
Journal:  J Clin Invest       Date:  2013-06-17       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.